Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/17/2001 | EP1069135A1 Proteins having immunomodulatory activity and remedies for immunological diseases |
01/17/2001 | EP1069134A1 Photorhabdus luminescens strains |
01/17/2001 | EP1069133A1 Neisseria meningitidis compounds and anti-infection applications thereof |
01/17/2001 | EP1068535A1 Method to detect biologically active, allergen-specific immunoglobulins |
01/17/2001 | EP1068530A1 Diagnostic for metastatic prostate cancer |
01/17/2001 | EP1068529A2 Methods and compounds for modulating nuclear receptor coactivator binding |
01/17/2001 | EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice |
01/17/2001 | EP1068522A1 Antigen |
01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
01/17/2001 | EP1068361A1 Diagnosis of multiple sclerosis and other demyelinating diseases |
01/17/2001 | EP1068357A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
01/17/2001 | EP1068347A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
01/17/2001 | EP1068339A1 Compositions and methods for protein secretion |
01/17/2001 | EP1068337A2 Mammalian gene encoding tolloid-like protein |
01/17/2001 | EP1068335A2 Cell cycle regulatory proteins |
01/17/2001 | EP1068334A2 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants |
01/17/2001 | EP1068331A1 Medicaments for inducing cytotoxic t-cells |
01/17/2001 | EP1068330A2 Recombinant potyvirus construct and use thereof |
01/17/2001 | EP1068329A2 FUSION PROTEINS OF $i(MYCOBACTERIUM TUBERCULOSIS) ANTIGENS AND THEIR USES |
01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
01/17/2001 | EP1068327A2 DNA IMMUNIZATION AGAINST $i(CHLAMYDIA) INFECTION |
01/17/2001 | EP1068326A1 Novel sequence class of genes, corresponding proteins and the use of the same |
01/17/2001 | EP1068325A2 Control of floral induction in plants and uses therefor |
01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
01/17/2001 | EP1068320A2 Prostapin gene and protein and uses thereof |
01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
01/17/2001 | EP1068316A1 Blk genes, gene products and uses thereof in apoptosis |
01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
01/17/2001 | EP1068314A1 Highly active forms of interferon regulatory factor proteins |
01/17/2001 | EP1068313A2 Collagen peptides and uses thereof |
01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
01/17/2001 | EP1068310A1 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1 |
01/17/2001 | EP1068309A2 Enterotoxin-deficient bacillus |
01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
01/17/2001 | EP1068307A1 Secreted proteins and polynucleotides encoding them |
01/17/2001 | EP1068303A2 Assay for the diagnosis of schizophrenia based on a new peptide |
01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
01/17/2001 | EP1068293A1 Vaccination modalities |
01/17/2001 | EP1068242A2 Immune response modulator alpha-2 macroglobulin complex |
01/17/2001 | EP1068240A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses |
01/17/2001 | EP1068239A2 Antioxidant peptides derived from apolipoprotein a-iv |
01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
01/17/2001 | EP1068237A1 T cell receptor expression cassette |
01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
01/17/2001 | EP1068235A1 G-protein coupled receptors |
01/17/2001 | EP1068234A2 Polypeptide domains capable of binding rho protein and their use in assays |
01/17/2001 | EP1068233A1 Transcription factors and their use |
01/17/2001 | EP1068232A2 Human antibiotic proteins |
01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
01/17/2001 | EP1068230A1 Chimeric insecticidal protein and gene coding therefore |
01/17/2001 | EP1068229A1 Peptides |
01/17/2001 | EP1068228A1 Protease conjugates |
01/17/2001 | EP1068227A1 Retrovirus envelope gylcoprotein mutants and biological applications |
01/17/2001 | EP1068226A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
01/17/2001 | EP1068225A2 New compounds for dna-transfection |
01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
01/17/2001 | EP1068220A1 nrdF |
01/17/2001 | EP1068218A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
01/17/2001 | EP1067964A1 Immunomodulatory compositions of mmtv antigens and methods of using same |
01/17/2001 | EP1067963A1 Hiv-specific cytotoxic t-cell responses |
01/17/2001 | EP1067962A2 Derivatives of pneumococcal choline binding proteins for vaccines |
01/17/2001 | EP1067961A2 Leishmania cysteine proteinases |
01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
01/17/2001 | EP1067950A1 Neo-tryptophan |
01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
01/17/2001 | EP0856008B1 Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers |
01/17/2001 | EP0794962A4 Dna-binding factor ctcf |
01/17/2001 | EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
01/17/2001 | EP0696198B1 Novel polypeptide having factor xa inhibitory activity |
01/17/2001 | EP0672158B1 Adenovirus with genetic fusion of penton fibre to peptide altering binding specificity |
01/17/2001 | EP0640135B1 Immunoglobulin binding proteins derived from l protein and their uses |
01/17/2001 | CN1280627A Proteinase inhibitor fusion proteins |
01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
01/17/2001 | CN1280617A TSA 305 gene |
01/17/2001 | CN1280616A Method and compositions for inducing tumor-specific cytotoxicity |
01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
01/17/2001 | CN1280586A Erythropoietin with high specific activity |
01/17/2001 | CN1280504A Vaccines with an LTB adjuvant |
01/17/2001 | CN1280503A Method of mobilizing hematopoietic stem cells |
01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
01/17/2001 | CN1280500A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
01/17/2001 | CN1280497A Mammalian-derived peptides for the treatment of microbial infection |
01/17/2001 | CN1280490A Peptide/lipid complex formation by co-lyophilization |
01/17/2001 | CN1280457A Nepovirus resistance in grapevine |
01/17/2001 | CN1280191A Method for producing nucleic acid inhibiting albumen by inducing and cultivating trichoid root of chinese trichosanthes |
01/17/2001 | CN1280185A Corynebaclerium for producing L-lysine and method for producing L-lysine |
01/17/2001 | CN1280184A Corgnebaclerium for producing L-lysine and method for preparing L-lysine |
01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
01/17/2001 | CN1280136A Gene sequence and amino-acid sequence of varient omega-conch toxin polypeptide and their preparing method and medicinal use |
01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
01/16/2001 | US6175000 Nucleic acids encoding human trithorax protein |